Navigation Links
Dr Ozone's Past Catches up with Him

Hellfried Sartori, known to most as the notorious Dr Ozone who used industrial solvent to treat terminal illnesses, has been found to have a history of alleged fraud//, malpractice and corruption spanning more than two decades in 14 American states.

Sartori, a convicted felon and discredited Austrian doctor has served five years jail in Virginia from 1999 and nine months in a New York jail in 1996.

Hellfried Erwin Sartori is also known as Professor Abdul-Haqq Sartori. He migrated to the US in 1976. While Sartori is hailed by some of his terminally ill patients as a potential saviour after they were deserted by conventional medicine, to the others, he is cynical, motivated only by greed inflicting great pain on patients using processes without any medical validity.

His unorthodox health remedies have come under investigation following the deaths of cancer sufferers in Australia and Thailand.

He was arrested in the city of Chiang Mai in Thailand this week on charges of fraud and unlicensed practice of medicine without a licence. Sartori however continues to claim his innocence.

WA police are waiting for results of pathology and toxicology tests obtained from the post mortems of seven cancer patients in Perth who died in quick succession in May and June 2005.

While Sartori himself was not in Australia at the time following the barring of his entry into the country from May 2005, police are investigating whether the six deaths were a result of receiving treatments by local adherents of Sartori's practices.

In the late 1980s Sartori eluded a possible long jail term when the family of a US patient, who died after a long span of enduring his treatment, did not want to have him charged with manslaughter because they were too distressed.

According to a legal source,"He would be still in jail now had he been convicted of manslaughter in Virginia where the charges were brought. He would have got 20 years."

That would have helped to curtail the damage that this medico inflicted on patients in several US states and overseas.


'"/>




Related medicine news :

1. Mid-Day Meal Scheme Catches on in India
2. Organic Food Fever Catches Up In Delhi
3. Hip Resurfacing Fever Catches on in US
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/29/2017)... ... 2017 , ... The Wharton School of the University of Pennsylvania is pleased ... a $10 million gift to establish the Ken Moelis and Julie Taffet Moelis ... a Wharton MBA for highly-qualified Penn undergraduates whose academic and career interests expand traditional ...
(Date:3/29/2017)... , ... March 29, 2017 , ... VisualSP has helped ... Until recently, the only option for on-premises installation of its Help System for SharePoint ... to install the system into the entire tenant. , The company recently released ...
(Date:3/28/2017)... ... 28, 2017 , ... Tuesday, March 28, 2017, is the annual American Diabetes ... Risk Test to find out if they are at risk for developing Type 2 ... the evening sky by programming the LAX pylons the color red. Downtown’s U.S. Bank ...
(Date:3/28/2017)... ... March 28, 2017 , ... India’s Chigurupati Technologies announced ... address the resolution to globally reduce the harmful use of alcohol set forth ... and TTB approved ingredients that when infused into alcohol, renders the alcohol liver ...
(Date:3/28/2017)... , ... March 28, 2017 , ... ... is pleased to be invited to the Siemens Healthineers annual customer education symposium, ... The event will take place from March 27 - 31, 2017 at the ...
Breaking Medicine News(10 mins):
(Date:3/29/2017)... 2017 Research and Markets has announced the ... report to their offering. ... The global energy-based aesthetic devices market to grow at ... The report, Global Energy-Based Aesthetic Devices Market 2017-2021, has been prepared ... The report covers the market landscape and its growth prospects over ...
(Date:3/29/2017)... , March 29, 2017  Novartis announced ... (FDA) has accepted the company,s Biologics License Application ... (tisagenlecleucel-T), an investigational chimeric antigen receptor T cell ... and young adult patients with B-cell acute lymphoblastic ... by Novartis for a CAR-T. The priority review ...
(Date:3/29/2017)...  The Global Health Innovative Technology Fund (GHIT ... battle infectious diseases around the globe, today announced ... help deliver a range of new innovative therapies ... This latest round of targeted support includes ... a pediatric formulation of a drug considered the ...
Breaking Medicine Technology: